Cargando…

Investigating the treatment phenotypes of cardiac sarcoidosis: A prospective cohort study()

INTRODUCTION: Data indicates there are 4 main pulmonary sarcoidosis duration/treatment phenotypes: asymptomatic, acute (disease duration <1–2 years), chronic and advanced. There are no data about disease duration/treatment phenotypes of cardiac sarcoidosis patients. Our study had 2 main aims (i)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiefels, Christiane, Weng, Willy, Beanlands, Rob, deKemp, Rob, Nery, Pablo B., Boczar, Kevin, Mesquita, Claudio Tinoco, Birnie, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333413/ https://www.ncbi.nlm.nih.gov/pubmed/37441681 http://dx.doi.org/10.1016/j.ahjo.2022.100224

Ejemplares similares

Negative Association of Smoking History With Clinically Manifest Cardiac Sarcoidosis: A Case-Control Study
por: Xu, Chenchen, et al.
Publicado: (2022)

FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET
por: Martineau, Patrick, et al.
Publicado: (2020)

Atrial Arrhythmias in Clinically Manifest Cardiac Sarcoidosis: Incidence, Burden, Predictors, and Outcomes
por: Weng, Willy, et al.
Publicado: (2020)

Exploring Occupational, Recreational, and Environmental Associations in Patients With Clinically Manifest Cardiac Sarcoidosis
por: Spence, Stewart D., et al.
Publicado: (2020)

Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review
por: Fazelpour, Siavosh, et al.
Publicado: (2021)

Incidence of Atrial Fibrillation as the Initial Manifestation of Cardiac Sarcoidosis: Insights From a Catheter Ablation Registry
por: De Bortoli, Alessandro, et al.
Publicado: (2023)

Management of ventricular tachycardia in patients with cardiac sarcoidosis
por: Viwe, Mtwesi, et al.
Publicado: (2021)

(82)Rb PET imaging of myocardial blood flow—have we achieved the 4 “R”s to support routine use?
por: deKemp, Robert A., et al.
Publicado: (2016)

Spontaneous coronary artery dissection in cardiac sarcoidosis
por: Kandolin, Riina, et al.
Publicado: (2019)

Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study
por: Boczar, Kevin E., et al.
Publicado: (2023)

Reproducible quantification of cardiac sympathetic innervation using graphical modeling of carbon-11-meta-hydroxyephedrine kinetics with dynamic PET-CT imaging
por: Wang, Tong, et al.
Publicado: (2018)

Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT(1) receptor expression as measured with PET imaging
por: Ismail, Basma, et al.
Publicado: (2017)

Rubidium-82 generator yield and efficiency for PET perfusion imaging: Comparison of two clinical systems
por: Ahmadi, Ali, et al.
Publicado: (2020)

Exponential dosing to standardize myocardial perfusion image quality with rubidium-82 PET
por: Tavoosi, Anahita, et al.
Publicado: (2023)

Cost-Effectiveness of Canakinumab From a Canadian Perspective for Recurrent Cardiovascular Events
por: Boczar, Kevin E., et al.
Publicado: (2022)

Cost-Effectiveness of Colchicine for Recurrent Cardiovascular Events
por: Boczar, Kevin E., et al.
Publicado: (2023)

The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial
por: Boczar, Kevin Emery, et al.
Publicado: (2023)

Decreased renal AT(1) receptor binding in rats after subtotal nephrectomy: PET study with [(18)F]FPyKYNE-losartan
por: Ismail, Basma, et al.
Publicado: (2016)

Consistent tracer administration profile improves test–retest repeatability of myocardial blood flow quantification with (82)Rb dynamic PET imaging
por: Klein, Ran, et al.
Publicado: (2016)

Optimally Repeatable Kinetic Model Variant for Myocardial Blood Flow Measurements with (82)Rb PET
por: Ocneanu, Adrian F., et al.
Publicado: (2017)

Saline-push improves rubidium-82 PET image quality
por: Renaud, Jennifer M., et al.
Publicado: (2018)

Bi-atrial fibrosis detected using three-dimensional late gadolinium enhancement magnetic resonance imaging in a patient with cardiac sarcoidosis(⋆)
por: Spence, Stewart, et al.
Publicado: (2018)

Chronic AMPK activity dysregulation produces myocardial insulin resistance in the human Arg302Gln-PRKAG2 glycogen storage disease mouse model
por: Thorn, Stephanie L, et al.
Publicado: (2013)

Current Practices in Myocardial Perfusion Scintigraphy in Brazil and Adherence to the IAEA Recommendations: Results of a Cross-Sectional Study
por: Rodrigues, Carlos Vitor Braga, et al.
Publicado: (2018)

Implantable cardiac devices in cardiac sarcoidosis: it is about preventing the unforeseeable
por: De Bortoli, Alessandro, et al.
Publicado: (2023)

Observational Cross-Sectional Study of Inflammatory Markers After Transient Ischemic Attacks, Acute Coronary Syndromes, and Vascular Stroke Events
por: Boczar, Kevin E., et al.
Publicado: (2020)

β2-adrenergic stress evaluation of coronary endothelial-dependent vasodilator function in mice using (11)C-acetate micro-PET imaging of myocardial blood flow and oxidative metabolism
por: Croteau, Etienne, et al.
Publicado: (2014)

Static CT myocardial perfusion imaging: image quality, artifacts including distribution and diagnostic performance compared to (82)Rb PET
por: Inácio, João R., et al.
Publicado: (2022)

Relationship of Electromechanical Dyssynchrony in Patients Submitted to CRT With LV Lead Implantation Guided by Gated Myocardial Perfusion Spect
por: do Nascimento, Erivelton Alessandro, et al.
Publicado: (2018)

Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis
por: Lehtonen, Jukka, et al.
Publicado: (2023)

Cardiac Sarcoidosis and Giant Cell Myocarditis: Actually, 2 Ends of the Same Disease?
por: Birnie, David H., et al.
Publicado: (2021)

Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease
por: Pelletier‐Galarneau, Matthieu, et al.
Publicado: (2017)

Outcome of catheter ablation of supraventricular tachyarrhythmias in cardiac sarcoidosis
por: Willy, Kevin, et al.
Publicado: (2019)

Sarcoidosis Phenotypes
por: Francesqui, Joel, et al.
Publicado: (2021)

Imaging atherosclerosis with hybrid [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: What Leonardo da Vinci could not see
por: Cocker, Myra S., et al.
Publicado: (2012)

Does Quantification of [(11)C]meta-hydroxyephedrine and [(13)N]ammonia Kinetics Improve Risk Stratification in Ischemic Cardiomyopathy
por: Wang, Jean Z., et al.
Publicado: (2022)

Clinical Features and Diagnosis of Cardiac Sarcoidosis
por: Tana, Claudio, et al.
Publicado: (2021)

Examining anti-inflammatory therapies in the prevention of cardiovascular events: protocol for a systematic review and network meta-analysis of randomised controlled trials
por: Boczar, Kevin Emery, et al.
Publicado: (2022)

Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART)
por: Kron, Jordana, et al.
Publicado: (2021)

Bidirectional ventricular tachycardia in cardiac sarcoidosis()
por: Benjamin, Mina M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_icb0n066cp79g90shoivrgui22